title: Combined treatment of pancreatic cancer with mithramycin a and tolfenamic Acid promotes sp1 degradation and synergistic antitumor activity--letter.
authors: Ting-Chao
authors: TC
authors: Chou
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D008926:Plicamycin / Q000008:administration & dosage / Q000031:analogs & derivatives; D016329:Sp1 Transcription Factor / Q000378:metabolism*; D062367:ortho-Aminobenzoates / Q000008:administration & dosage
chemical_list: D016329:Sp1 Transcription Factor; D062367:ortho-Aminobenzoates; C009500:tolfenamic acid; C066851:mithramycin A; D008926:Plicamycin